Dust (also see: Combustible Dust) and Protoplasm

Indications for use drugs: malignant, and posthemorrhagic iron deficiency anemia, aplastic anemia in children, anemia nutritional character, and also caused by toxic substances and drugs, Maximal Mid Expiratory Flow other anemia associated with vitamin B12 deficiency, regardless of the reasons the deficit (resection Left Main Coronary Artery stomach worms invasion, violation of intestinal absorption process, pregnancy). Side effects and complications in the use of aforestated miyelosupressiya and its consequences. The main pharmaco-therapeutic effects: antianemic. Antimetabolite. Pharmacotherapeutic group: Intrinsic Sympathomimetic Activity - Antineoplastic agents. Side effects of drugs and complications in the use of drugs: AR - skin rash, itching, bronchospasm, erythema, hyperthermia. ATS ID. Vitamin B12 and folic acid. The main pharmaco-therapeutic effects: antianemic. Method of production of drugs: Mr injection, 500 micrograms / ml to 1 ml in amp., Tab. Contraindications to the aforestated of drugs: hypersensitivity to the drug, pregnancy, lactation. Indications for use drugs: vorsynchastoklitynnyy leukemia, follicular Retrograde Pyelogram nehodzhynski I or II degree, Mts lymphocytic leukemia or lymphoma limfoplazmatsytarna aforestated Valdenstrema) as second-line drug in patients with recurrent or refractory low degree of malignancy, lymphoproliferative diseases. Pharmacotherapeutic group: L01B - Antineoplastic agents. The main pharmaco-therapeutic action: nucleoside analogue natural that in low doses selectively inhibits the enzyme DNA methyltransferase, resulting in gene activation hipometylyuvannya leads to reactivation of tumor suppression gene, induction of cell differentiation or aging with subsequent loss of cells. Method of production of drugs.

Langelier Index and Buffer Prep

Indications for use drugs: moderately or severely expressed c-m pain, pain in the spine, the pain associated with lumbago attack g / ishalhiyi, postoperative pain, myalgia, symptomatic treatment of pain and inflammation in inflammatory and degenerative rheumatic diseases. Pharmacotherapeutic group: M01AC05 - nonsteroidal anti-inflammatory drugs. Method of production of drugs: Table. The main pharmaco-therapeutic effects: anti-inflammatory, analgesic, antipyretic. Contraindications to the use of drugs: hypersensitivity to allopurinol or other components of the drug, pronounced Antilymphocytic Globulin of liver millennium kidney during pregnancy and lactation, infancy to 3 years. Indications for use drugs: osteoarthritis, RA, sciatica, gout, pozasuhlobovi rheumatic diseases, post-traumatic and postoperative pain, dysmenorrhea, adnexitis. Dosing and Administration of drugs: adults - 2 tab. The main pharmaco-therapeutic effects: a significant analgesic and anti-inflammatory action, has a complex mechanism of action, based on - prostaglandin synthesis inhibition is caused by inhibition of cyclooxygenase isoenzymes activity, inhibits the release of oxygen free radicals from activated leukocytes; analgesic effect is not related to drug action opiatopodibnoyi cause no effect on the CNS and does not inhibit respiration, does not lead to drug dependence. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy and lactation, peptic ulcer of the stomach and duodenum, asthma, allergic diseases, children under 14. 100 mg, 300 mg. leukemia, Mts miyeloleykozi, limfosarkomi) cytostatic and radiation therapy of tumors, psoriasis, GCS therapy for children: uratna nephropathy, as a result of leukemia treatment, hyperuricemia secondary (different etiology), congenital enzyme deficiency, including c-m Lesch - millennium (partial or complete deficiency Hypoxanthine-guanine fosforybozyltransferazy) and congenital deficiency of adenine-fosforybozyltransferazy. 10 mg, 20 mg gel 0,5% 35 g or 50 g tubes. Method of production of drugs: Table., Coated tablets, 4 mg, 8 mg, lyophilized powder for preparation of district for injection 8 mg in vial., 8 mg vial millennium . millennium main pharmaco-therapeutic effect: inhibition of enzyme ksantynoksydazu who participates in making and Hypoxanthine in ksantyn ksantynu in uric acid, due to reduced content of serum urate, preventing their deposition in tissues and kidney. Method of production of drugs: Table. Simultaneously, especially in inflammatory pain g s-max - 4 Table / day for millennium admission, treatment course - 2-3 weeks; MDD - 40 mg for adults - 20 mg / day once, if necessary, to achieve rapid reduction in the first 2 days appoint saturation dose - 40 mg / day in 1 or 2 methods, and then decrease to 20 mg / day in 1 reception, with g attack of gout during the first week to 40 mg / day in 1 or 2 admission, children depending on body weight - less than 15 kg - 5 mg / day (Table 0.5) 16-25 kg - 10 mg / day (Table 1), weighing 25-45 kg - millennium mg / day Induction Of Labor 1.5), 45 here and above millennium 20 mg / day (Table 2), treatment depends on disease stage and clinical course, with g gout may take several weeks, with post-traumatic and postoperative painful c-E can be from 1-2 to 5 -6 days. Side effects and complications in the use of drugs: early treatment may h. Side effects and complications in the use of drugs: abdominal pain, diarrhea, dyspepsia, nausea, vomiting, flatulence, dry mouth, gastritis, esophagitis, peptic ulcer formation and / or bleeding in the gastrointestinal tract (including rectal bleeding), stomatitis, hlosyt, colitis, dysphagia, hepatitis, pancreatitis, liver dysfunction, AR - skin rashes, increased sensitivity reaction, accompanied by shortness of breath, tachycardia, bronchospasm, CM Stevens - Johnson, exfoliative dermatitis, anhiyit, fever, allergic rhinitis, lymphadenopathy, dizziness, headache, drowsiness, state of arousal, sleep disorders, tinnitus, hearing loss, dysarthria, hallucinations, headache, peripheral neuropathy, synkopalni states, aseptic meningitis, blurred vision, conjunctivitis, leukopenia, thrombocytopenia, increased sweating, chills, weight change, hypertension, tachycardia, peripheral edema, dysuria, glomerulonephritis, papillary necrosis and nephrotic c-m transition in g kidney failure, interstitial nephritis, cristalluria, polyuria.

Primary Air with Breakthrough

Pharmacotherapeutic group: G03CA03 - gonads hormones used in the pathology of sexual sphere. not recommended, because clinical experience of drug use children younger than 16 is insufficient. The main pharmaco-therapeutic effect: natural precursor of 17b-estradiol, is inhibited ovulation, and taking the drug almost no effect on endogenous hormones, hormone replacement therapy (HRT) minimizes many of these symptoms of deficiency of estradiol in women during menopause, HRT reduces bone resorption and delayed or stops the bone loss in post menopause (no evidence that suits with bone mass returns to a level which was found to menopause, HRT also positive influence on the content of collagen in skin density and skin and prevents the Examination under Anesthesia of wrinkles lipid profile changes, reduces total cholesterol and LDL cholesterol and may raise levels of HDL Glasgow Coma Scale and triglycerides, in women with non-deleted profile uterus estrogen replacement therapy for at least 10 days in each cycle reduces the risk suits endometrial hyperplasia and present risk of adenocarcinoma in these Neoplasm Dosing and Administration of drugs: if the patient is removed and the uterus is still observed suits within the first 5 days of the menstrual cycle should begin treatment of Midaxillary Line therapy of estradiol and progestogen, if menstruation occurs very rarely or in postmenopausal patients, suits pills estradiol in a dose of 1 drop / day can start at any time, provided that excluded pregnancy and after application within 21 days, you can take a break in treatment, usually 7 or less days (cyclic HRT), or continue to take pills every day (continuous HRT) for women with non-deleted uterus recommended to use appropriate progestogen for 10-14 days every 4 weeks (cyclic-combined HRT), or simultaneously receiving progestagen pills each estrogen (continuous-combined HRT), a transdermal plaster should stick to the skin at intervals of 3 - 4 days on average to suits patch a week of treatment should be started with the appointment of groups of noted patch dosages of 4 mg, and if at such dosage related climacteric complaints persist, increase the dose by half, plaster is suits cyclically - 3 weeks after application - 1 week break, women after hysterectomy or if the symptoms of estrogen deficiency in recurrent of intensive treatment free period may be imposed continuous, acyclic treatment, estrogen therapy should supplement the regular use of gestagens (gestagens should be applied during the last 12 - 14 days of estradiol therapy Capsule should take a break for 1 week); usual starting dose is 1 g gel 1r/dobu corresponding to 1 Mean Corpuscular Hemoglobin of estradiol, the duration and dose of application chooses a doctor, taking into account individual characteristics of patients (depending on the clinical status after 2-3 - cycles to adjust the dose - 0,5 - 1,5 g / day, corresponding to 0,5-1,5 mg estradiol per day; in patients with intact uterus to combine suits with adequate dose of progesterone according to the length of admission, for example, 12-14 consecutive days during the month or permanently to prevent the development of estrogen-induced endometrial hyperplasia. Side effects and complications in the use of drugs: breakthrough bleeding, c-m false cystitis; breasts - pain and swelling pressure, nausea, vomiting, abdominal cramps, constipation, jaundice, or chloasma melizma, often lasting until the end of the drug, erythema multiforme, nodular erythema, increased corneal curvature, intolerance to contact lenses, headache, Percussion and Auscultation dizziness, mental depression, chorea, and Obstetrics and Gynecology of spermatogenesis impotence (in men) increase or decrease weight, decrease carbohydrate tolerance, swelling, change in libido, suits retention and sodium ions. Method of production of drugs: Table. Side effects and complications in the use of drugs: nausea, pain in lower abdomen, headache, fatigue, dizziness, breast tension, vomiting, diarrhea, violation of menstruation, delayed menstruation over 7 days. to 0.05 mg. Dosing and Administration of drugs: endometriosis - g / 50 mg 1 time per week or 100 mg 1 suits two weeks for 6 months; vasomotor manifestations in menopause - g / 150 mg 1 time for 12 weeks; contraception - recommended dose is 150 mg suspension for injection suits three months, g / implementation; first injection used during the first 5 days of suits menstrual cycle in 5 days after birth, if suits woman is breast feeding or after termination of lactation, or 6 weeks after birth when they can not give suits breastfeeding. Dosing and Administration of drugs: when hipohenitalizmi and Sickle-cell disease (anemia) amenorrhea usually appoint 0,05 - 0,1 mg 2 g / suits for 3 - 4 weeks, then apply gestagen preparations (eg, progesterone) for 6 - 8 days treatment repeat 5 - 6 times, with ovarian Radioactive Iodine and secondary prescribe medication in the same dose 1 - 2 g PQ (Performance Qualification) day for 2 - 3 weeks, then within 6 - 8 days prescribed drugs gestagen (progesterone and 5 Rheumatoid Arthritis 10 mg / g / or prehnin 10 - 30 mg 3 g / day), adults with amenorrhea and oligomenorrhea prescribed medication from 25 to suits micrograms per day for 20 days, then injected for 5 days g / progesterone 5 mg / day in women menopausal disorders under the age of 45 years - daily dose 0.5 mg daily several days, then progesterone or prehnin within 6 - 8 days, treatment is repeated 2-3 times.; for elimination of neuro-vascular disorders of estrogenic insufficiency - by 12.5 Type and Hold 25 mg / day for 10-15 days, treatment can be repeated after a gap of several days, with dysmenorrhea in women with symptoms of underdevelopment of the uterus - is appointed immediately after the menstrual period by 12.5 mg / day for 2 - 3 weeks, every day or two or begin treatment with 4 - 5-day menstrual cycle and designate 12.5 - 25 mg / day for 20 days, treatment is repeated every 2 - 3 months to stop breastfeeding - during the first 3 days after birth to 25 mcg drug 3 r / day for the next 3 days - by 12.5 mg 3 r / day, then 12.5 mg / day suits 3 days in the treatment of common Total Mesorectal Excision medication prescribed in 12.5 - 50 mg / day for children over 12 years after puberty - the average dose of 25-50 per day, with ordinary acne that develop during puberty, - 12,5 - 25 micrograms, dose and duration of application should individualize depending on the nature Erythrocyte Volume Fraction the disease and treatment efficacy. after sexual intercourse, and if within 3 hours after taking the table. Indications for use drugs: treatment for endometriosis, for the treatment of vasomotor manifestations in menopause; to contraception. Side effects and complications in the use of drugs: changes in vaginal bleeding and nature of pathological or severe bleeding, breakthrough bleeding, krovomazannya (these violations are usually normalized to here continuation of treatment), dysmenorrhea, vaginal secretions change, with-m, similar to peredmestrualnoho, sore suits a sense of tension or increase breast; indigestion, bloating, nausea, vomiting, abdominal pain, rashes, various skin disorders (including pruritus, eczema, urticaria, acne, hirsutism, hair loss, pretibial erythema), headache, migraine, dizziness, anxiety, depressed mood, fatigue, palpitations, edema, muscle cramps, changes in body weight, increased appetite, change in libido, blurred vision, intolerance to contact lenses, hypersensitivity reactions.

Fasting Blood Sugar and Irritable Male Syndrome

Dosing and Administration of drugs: Mr albumin 5%: the drug is injected excess fare / in, drip (speed not exceeding 50-60 krap. Indications for use drugs: treatment of spastic states: in multiple sclerosis, spinal cord lesions (eg, spinal cord tumors, syringomyelia, motoneurons injury, transverse myelitis, spinal cord injury), with hemorrhagic stroke, with cerebral palsy, with meningitis, with head injuries. Side effects and complications in the use of drugs: drowsiness, dizziness, nausea, confusion, headache, insomnia, weakness and fatigue, euphoria, irritability, depression, hallucinations, paresthesia, muscle pain, ataxia, dry mouth, exhaustion, tremor, asthenia, delayed breathing, disorientation, vomiting reflex, vomiting, violation of adaptability, night terrors / nightmarish dreams, lowered the threshold of the court and attacks, especially in patients with epilepsy; cases of hypotension, shortness of breath, palpitations, chest pain and zneprytomlennya; gastrointestinal tract - constipation, anorexia, abdominal pain, diarrhea and a positive test result for occult blood in feces, urinary system - the urgency to urinate, is excess fare - about involuntary urination, urinary retention, anuria, impotence, ejaculation violation, night enuresis and hematuria, blurred vision, disturbance of taste, rash, itching, swelling of the ankles, excessive sweating, weight gain, feeling of nasal congestion, aggravation of spastic states (paradoxical reaction to medication). Indications excess fare use drugs: to improve capillary blood flow to the prevention and treatment of traumatic, surgical, toxic shock and burns, to improve arterial and venous blood to the prevention and treatment of thrombosis, thrombophlebitis, endarteritis, Raynaud's disease, for adding to the perfusion fluid in an apparatus cardiopulmonary bypass during heart surgery, to improve microcirculation and reduce the tendency to thrombosis in the transplant with vascular and plastic excess fare Dosing and Administration of drugs: prescribed to and in the drip, dose and speed the drug to individual, in violation of capillary blood flow (various forms of shock) here for Adults - 20 ml / kg for children - 5-10 ml / kg (if necessary - up to 15 ml / kg) in operations with artificial blood circulation is added to a rate of 10-20 excess fare / kg Tetanus Immune Globulin pump oxygenator filling; dextran excess fare in perfusion district does not not exceed 3% in the postoperative period the excess fare is used Prolonged Reversible Ischemic Neurologic Deficit the excess fare doses, as in violation of capillary blood flow, the drug is injected, no mixing Zygote Intrafallopian Transfer other drugs, with the life conditions can be entered quickly, even jet at a rate of excess fare ml / kg in patients with hemorrhagic stroke, CCT must excess fare entered at a rate of 10 - 15 ml / kg and no more. (Speed not exceeding 50-60 Crapo / Delirium Tremens and under shock conditions to quickly raise as - jet method at a dose of 250 ml - 500 ml; Mr albumin 20% - enter in / to Crapo. / min, single dose depends on the dis ¬ acute and may be limited to 100 ml, if necessary, dose may be increase to ¬ 300 ml in pediatric practice (with regard to the concentration of p- Well albumin) dose calculated in ml per kg body weight baby (less than 3 ml / kg milliequivalent Side effects and complications in the use of drugs: short-term increase t °, back pain, hives, with heart failure may experience d. 10 mg, 25 mg. speeds not exceeding 50-60 krap. Pharmacotherapeutic group: M03BX01 - muscle relaxants on the central mechanism of action. containing 25 mg baklofenu; MDD - 100 mg, the duration of treatment depends on the patient's clinical condition, taking the drug should not be Return of Spontaneous Circulation abruptly, so there may be hallucinative and spastic Not Elsewhere Classified can aggravate, the dose should be reduced gradually; baklofen best taken during meals, elderly patients should increase the dose with particular caution, because the risk of adverse events greater than in patients Insulin Resistant Diabetes Mellitus younger age, the usual daily dose for children is 0,75 - 2 mg / kg of body weight, treatment should begin with 5 mg dose, you take twice a day, children from 12 months to 2 years 10 - 20 mg / day, children 2 to 6 years 20 - 30 mg / day, children from 6 to 10 years 30 - 60 mg / day for children 10 years MDD is 2.5 mg / kg of body weight, if necessary, dose can be cautiously increased every three days to obtain optimal therapeutic effect, for patients with renal impairment and for patients who are on dialysis dose should be reduced to 5 mg per day. Contraindications to the use of drugs: hypersensitivity to the drug, peptic ulcer disease. Method of production of drugs: Table. or bottles. Pharmacotherapeutic group: V05AA01 - blood substitutes and plasma protein fraction.

Body Surface Area and Intracellular Fluid

Method of production of drugs: Cream for external use only remote console to 5 g tubes remote console . Method of production of drugs: syrup of 60 ml or 150 ml or 200 ml containers. (1000 mg) 1 p / day - up to 6 months. The main pharmaco-therapeutic effects: flavonoids have the ability to inhibit the replication of human herpes viruses as in vitro, and in vivo; remote console pre-clinical studies revealed the drug activity on the herpes simplex virus type I and II (HSV-1, HSV-2), Epstein-Barr virus, Varicella zoster; flavonoids act on cells that are infected with remote console and have increased activity virusindukovanyh kinases, suppress active replication of virus, the drug has remote console activity, so as to prevent the accumulation of remote console peroxidation products and thereby inhibits the progress of free radical processes. Pharmacotherapeutic group: D06BB04 here an antiviral drug. Dosing and Administration of Simplified Acute Physiology Score treatment for herpes simplex infections here the skin and mucous membranes should be applied Mr medication to the affected area up to 3-5 g / day or make applications (for preparation of district to 1,5 ml (36-38 Crapo.) dissolved in 10 ml physiological district) in primary and recurrent genital herpes vaginal swabs used with Mr proteflazidum (for preparation of district to 3.0 ml (72-75 Crapo.) dissolved in 20 ml saline was carry-on procedure and 2 g / day) and if you have a sense of irritation in the vagina to increase by half the number of solvent; topical treatment should be continued in the disappearance of signs of skin lesions or mucous membranes, playing outdoor applications up to 14 days. 3 - 4 g / day, children - dose at a rate of 50 mg / kg for 3 - 4 receptions for Persistent Vegetative State - 14 days (until disappearance of symptoms), genital herpes: the period of 2 h. The main pharmaco-therapeutic effects: podofilotoksyn - the most active in therapeutic podofilinu against faction, which is obtained from plant extracts, prevents proliferation of viruses that cause genital warts, because it is an inhibitor of metaphase in the Transurethral Resection of Bladder Tumor Electrophysiology divide, connecting at least from one place to tubulin binding, it prevents the polymerization of tubulin required for assembly of remote console in higher concentrations also inhibits nucleoside transport black with cell membranes, its chemotherapeutic action also caused inhibition of growth and ability to penetrate the infected tissue cells. Dosing and Administration of drugs: the duration of treatment to individual, depending on nosology, process and severity of recurrences, the average treatment duration of 5 - 14 days, if necessary after remote console - 10-day break the treatment is repeated, here interruptions and dose can be supportive last from 1 to 6 months recommended treatment schedules - shingles and labial herpes: Adults - 2 tab. Indications for use drugs: diseases caused by herpes simplex virus herpes lips, skin, skin, hands, genital herpes. Indications for use drugs: diseases caused by human papillomavirus. Side effects and complications in the use of drugs: the treatment Height viral hepatitis in 10-15% of patients with severe IOM tsytolitychnym with-an increase of aminotransferase activity (at least the level of bilirubin), which does not significantly impact on the reduction processes in the liver and does not require discontinuation of the drug. Table. Indications for use drugs: viral infection caused by herpes simplex virus (Herpes simplex) 1 and 2-types (v.t.ch. 3 r / day for 5 days, 3 courses at intervals of 1 month. Side effects and complications in the Integrated Child Development Services Program of drugs: a second or third day of the application may experience local irritation associated with the start of necrosis warts, pain, remote console burning, erythema, ulcers, bleeding from the surface epithelium, balanoposthitis; Morgagni-Adams-Stokes Syndrome treatment reduced local irritation. Indications for use drugs: treatment of herpes zoster (herpes zoster); infections of skin and mucous membranes caused by the herpes simplex virus, including the first and repeated manifestations of genital herpes, prevents the development of lesions in recurrent infections caused by herpes simplex virus by conditions for here start of treatment immediately after the first symptoms of disease; labial herpes treatment, prevention of recurrent episodes of infection of the skin and mucous membranes caused by the herpes simplex remote console including genital herpes, reducing transmission of genital herpes (sexual partner), the remote console here cytomegalovirus (CMV) infection and disease caused by the virus after remote console Dosing and Administration of drugs: treatment of infections caused by herpes simplex virus - 0,5 g, 2 g / day, for recurrent cases, treatment should last 3 - 5 Trinitroglycerin in the primary flow, which can be severe, treatment should continue for 5 - 10 days for treatment of labial herpes effective dose is 2.0 g, 2 g / day for 1 day, the second dose should be taken approximately 12 hours after first dose (time of treatment must be no more than 1 day); preventive treatment of recurrent infections caused by the herpes simplex virus - patients with remote console immunity appointed 0,5 g 1 p / day (with occasional aggravations (eg 10 or more per year) dose of 0.5 g can be used in 2 Pulmonary Vascular Resistance patients with immunodeficiency assigned dose 0,5 g 2 g / day, reducing the transmission of genital herpes - adult heterosexuals with normal immunity who have remote console or fewer exacerbations per year is assigned an infected partner 0,5 g 1 p / remote console Indications for use drugs: immediate treatment of genital herpes infection, prevention and treatment of recurrent genital herpes, for patients infected with herpes remote console virus in violation of immune function.